Recent advances in S-adenosyl-L-homocysteine hydrolase inhibitors and their potential clinical applications

Author： Yuan C-S. Saso Y. Lazarides E. Borchardt R.T. Robins M.J.

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.9, Iss.9, 1999-09, pp. : 1197-1206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting “Hydrolytic” Activity of the S-Adenosyl-L- Homocysteine Hydrolase

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 3, 2001-09 ,pp. : 307-316

Bentham Science Publishers

Access to resources Recommend Favorite

S-Adenosyl-l-homocysteine and 5'-methylthioadenosine inhibit binding of [ 3 H]flunitrazepam to rat brain membranes

By Tsvetnitsky V. Campbell I.C. Gibbons W.A.

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 255-258

Elsevier

Access to resources Recommend Favorite

Recent advances in the discovery and evaluation of fatty acid amide hydrolase inhibitors

By Deng Hongfeng

Expert Opinion on Drug Discovery, Vol. 5, Iss. 10, 2010-10 ,pp. : 961-993

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Thymidine Kinase 2 (TK2) Inhibitors and New Perspectives for Potential Applications

Current Pharmaceutical Design, Vol. 18, Iss. 20, 2012-07 ,pp. : 2981-2994

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances of MEK Inhibitors and Their Clinical Progress

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 14, 2007-01 ,pp. : 1364-1378

Bentham Science Publishers

Access to resources Recommend Favorite